HemoGenyx Company
New treatment for blood diseases, such as leukemia and lymphoma.
Technology:
Cell therapy
Industry:
Public
Headquarters:
Buffalo, New York, United States
Founded Date:
2013-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
2
Total Funding:
61250000
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-11-18
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership